What is J.P. Morgan's price target for APLS?

J.P. Morgan's latest stated price target for Apellis Pharmaceuticals Inc. (APLS) is $81, from its action on Oct 6, 2023.

What is J.P. Morgan's rating on APLS?

J.P. Morgan rates APLS Overweight, a bullish rating, as of Oct 6, 2023.

When did J.P. Morgan last change its view on APLS?

On Oct 6, 2023, J.P. Morgan upgrades to Overweight from Neutral, price target $60 to $81.

Analyst firms · J.P. Morgan · APLS

J.P. Morgan APLS price target and rating history

Apellis Pharmaceuticals Inc. (APLS) · Health Care

J.P. Morgan rates Apellis Pharmaceuticals Inc. (APLS) Overweight with a $81 price target, as of its latest action on Oct 6, 2023. It has published 3 rating actions on APLS since July 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a APLS price target in the last 12 months, the median target is $28.

Current rating: Overweight
Price target: $81
Median target, all firms: $28
Actions on APLS: 3

J.P. Morgan price target on APLS

J.P. Morgan price target on APLS, each point a stated target, July 2021 to October 2023.

Every J.P. Morgan rating on APLS

Oct 6, 2023
UpgradeJ.P. Morgan upgrades to Overweight from Neutral, price target $60 to $81
Aug 3, 2023
DowngradeJ.P. Morgan downgrades to Neutral from Overweight, price target $72 to $60
Jul 2, 2021
ReiterateJ.P. Morgan raises its price target to $101 from $91, keeps Overweight

How other firms rate APLS

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Roth Capital	Buy	$31	Mar 13, 2026
Barclays	Equal Weight	$24	Jan 28, 2026
BofA Securities	Buy	$28	Jan 21, 2026

Questions about J.P. Morgan and APLS

What is J.P. Morgan's price target for APLS?: J.P. Morgan's latest stated price target for Apellis Pharmaceuticals Inc. (APLS) is $81, from its action on Oct 6, 2023.
What is J.P. Morgan's rating on APLS?: J.P. Morgan rates APLS Overweight, a bullish rating, as of Oct 6, 2023.
When did J.P. Morgan last change its view on APLS?: On Oct 6, 2023, J.P. Morgan upgrades to Overweight from Neutral, price target $60 to $81.
How does J.P. Morgan's APLS target compare with other analysts?: Across 3 firms with a APLS price target in the last 12 months, the median target is $28.

More APLS rating histories

All J.P. Morgan ratings APLS news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.